Autoantibody Response Toward Chromatin in Patients With Juvenile Idiopathic Arthritis
Objective Patients with juvenile idiopathic arthritis (JIA) frequently exhibit antinuclear antibodies (ANAs), but the specific antigen target recognized by them and the presence of additional autoantibody specificities in patients with JIA remains elusive.
Viola Pitkänen +13 more
wiley +1 more source
Septic Shock in Hematological Malignancies: Role of Artificial Intelligence in Predicting Outcomes. [PDF]
Alvaro ME +6 more
europepmc +1 more source
Serum cytokine profiling differentiates underlying diseases in cytokine storm syndrome
Objective Cytokine storm syndrome (CSS), commonly associated with hemophagocytic lymphohistiocytosis (HLH), is a fatal hyperinflammatory syndrome. Differentiating the underlying diseases responsible for CSS is essential for timely therapeutic decisions. This study explored the clinical usefulness of serum cytokine profiling in distinguishing underlying
Shuya Kaneko +42 more
wiley +1 more source
Racial differences in outcomes among patients with septic shock: A national cohort study. [PDF]
Ang SP, Chia JE, Iglesias J.
europepmc +1 more source
Objectives The aim of this study was to compare differences in clinical response, drug survival, and adverse event rates between anakinra and canakinumab in VEXAS syndrome. Methods This multicenter international study includes VEXAS patients from France, Israel, and Italy treated with IL1 inhibition (IL1i).
Tali Eviatar +35 more
wiley +1 more source
Adjunctive terlipressin versus placebo in the treatment of refractory septic shock: a randomized, placebo-controlled trial. [PDF]
Tongyoo S +3 more
europepmc +1 more source
Objective Systemic lupus erythematosus (SLE) is characterized by increased type I interferon (IFN‐I) and autoantibody production. This study aimed to identify drugs that can inhibit both IFN‐I and autoantibody production. Methods We identified an inhibitor of IFN‐I production from a chemical library.
Takehiro Hirayama +16 more
wiley +1 more source
Hyperferritinemia and Macrophage Activation Syndrome in Septic Shock: Recent Advances with a Pediatric Focus (2020-2025). [PDF]
Briassouli E, Syrimi N, Ilia S.
europepmc +1 more source
New insights into the pathogenesis and therapy of septic shock
Martin Llewelyn, Jonathan Cohen
openalex
Initial fluid resuscitation in septic shock: Reassessing the 30 mL/kg paradigm. [PDF]
Teboul JL, Liu J, Hamzaoui O.
europepmc +1 more source

